DexCom beat expectations in the third quarter, and it raised its revenue guidance for the full year. Manufacturing issues are putting pressure on margins. For 2026, the company sees growth missing ...

Thank you, operator, and welcome to DexCom's Third Quarter 2025 Earnings Call. Our agenda begins with Jake Leach, DexCom's President and Interim CEO, who will summarize our recent highlights and ...

SAN DIEGO (AP) — SAN DIEGO (AP) — DexCom Inc. (DXCM) on Thursday reported third-quarter net income of $283.8 million. The San Diego-based company said it had net income of 70 cents per share. Earnings ...

As of October 30, 2025, the average one-year price target for DexCom is $102.13/share. The forecasts range from a low of $85.07 to a high of $126.00. The average price target represents an increase of ...

Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action lawsuit on behalf of purchasers and acquirers of DexCom, Inc. (NASDAQ: DXCM) securities between ...

Abstract: The attack of false data injection can contaminate the measurements acquired from the supervisory control and data acquisition (SCADA) system, which can seriously endanger the safety and ...

Abstract: This study investigates the vulnerability of dc microgrid systems to cyber threats, focusing on false data injection attacks (FDIAs) affecting sensor measurements. These attacks pose ...

Stifel resumed coverage with a Buy rating, highlighting the potential of DexCom’s 15-day sensor and growing market share in the Type 2 diabetes segment. TD Cowen also reiterated a Buy rating and a ...